• 1
    Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am J Obstet Gynecol 1988; 158: 8083.
  • 2
    Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130137.
  • 3
    Bukowski R, Carpenter M, Conway D, Coustan D, Dudley DJ, Goldenberg RL, Hogue CJ, Koch MA, Parker CB, Pinar H, Reddy UM, Saade GR, Silver RM, Stoll BJ, Varner MW, Willinger M; Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA 2011; 306: 24592468.
  • 4
    Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997; 104: 450459.
  • 5
    Roberge S, Giguere Y, Villa P, Nicolaides K, Vainio M, Forest JC, von Dadelzen P, Vaiman D, Tapp S, Bujold E. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012; 29: 551556.
  • 6
    Roberge S, Villa P, Nicolaides K, Giguere Y, Vainio M, Bakthi A, Ebrashy A, Bujold E. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141146.
  • 7
    Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402414.
  • 8
    Lyall F. Priming and remodelling of human placental bed spiral arteries during pregnancy – a review. Placenta 2005; 26 Suppl A: S31–S36.
  • 9
    Vainio M, Kujansuu E, Koivisto AM, Maenpaa J. Bilateral notching of uterine arteries at 12–14 weeks of gestation for prediction of hypertensive disorders of pregnancy. Acta Obstet Gynecol Scand 2005; 84: 10621067.
  • 10
    Haapsamo M, Martikainen H, Rasanen J. Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Ultrasound Obstet Gynecol 2008; 32: 687693.
  • 11
    Espinoza J, Romero R, Mee Kim Y, Kusanovic JP, Hassan S, Erez O, Gotsch F, Than NG, Papp Z, Jai Kim C. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006; 34: 447458.
  • 12
    Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980; 1: 319.
  • 13
    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 17911798.
  • 14
    Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007; CD004659.
  • 15
    Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan K. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003; 101: 13191332.
  • 16
    Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguere Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009; 31: 818826.
  • 17
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
  • 18
    Cochrane Handbook for Systematic Reviews of Interventions, version 5.1.0 (updated March 2011). Higgins JPT, Green S (eds). The Cochrane Collaboration, 2011. Available from
  • 19
    Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408412.
  • 20
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177188.
  • 21
    Chevalier P, van Driel M, Vermeire E. Hétérogénité dans les synthèses méthodiques et méta-analyses. Minerva 2007; 6: 160.
  • 22
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557560.
  • 23
    Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11: 193206.
  • 24
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629634.
  • 25
    August P, Helseth G, Edersheim T, Hutson J, Druzin M. Sustained relase, low-dose aspirin ameliorates but does not prevent preeclampsia (PE) in a high risk population. Proceedings of the 9th International Congress, International Society for the Study of Hypertension, March 15–18, 1994, Sydney, Australia. Hypertension in Pregnancy, p. 72.
  • 26
    Azar R, Turpin D. Effect of antiplatelet therapy in women at high risk for pregnancy-induced hypertension. Proceedings of the 7th World Congress of Hypertension in Pregnancy. October 1990, Perugia, Italy, p. 257.
  • 27
    Beaufils M, Uzan S, Donsimoni R, Colau JC. Prevention of pre-eclampsia by early antiplatelet therapy. Lancet 1985; 1: 840842.
  • 28
    Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R, Gastaldi A, Remuzzi G. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357362.
  • 29
    Bakhti A, Vaiman D. Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertens Res 2011; 34: 11161120.
  • 30
    Bakhti A, Vaiman D. Erratum: prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation (2012; 34: 1116). Hypertens Res 2012; 35: 244.
  • 31
    Chiaffarino F, Parazzini F, Paladini D, Acaia B, Ossola W, Marozio L, Facchinetti F, Del Giudice A. A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2004; 112: 142144.
  • 32
    Dasari R, Narang A, Vasishta K, Garewal G. Effect of maternal low dose aspirin on neonatal platelet function. Indian Pediatr 1998; 35: 507511.
  • 33
    Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14–16 weeks pregnancy: randomized controlled clinical trial. Croat Med J 2005; 46: 826831.
  • 34
    Hermida RC, Ayala DE, Iglesias M, Mojon A, Silva I, Ucieda R, Fernandez JR. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 1997; 30: 589595.
  • 35
    Hermida RC, Ayala DE, Fernandez JR, Mojon A, Alonso I, Silva I, Ucieda R, Codesido J, Iglesias M. Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension 1999; 34: 10161023.
  • 36
    Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int 2012 Sep 24. [Epub ahead of print].
  • 37
    Mesdaghinia E, Talari H, Abedzadeh-Kalahroudi M. Effect of aspirin for prevention of preeclampsia in women with abnormal ultrasonic findings in uterine artery. Feyz, J Kashan University Med Sci 2011; 15: 98104.
  • 38
    Michael CA, Walters BNJ. Low-dose aspirin in the prevention of pre-eclampsia: current evaluation. In Maternal Physiology and Pathology. The Current Status of Gynaecology and Obstetrics Series. Teoh ES, Ratnam SS, Macnaughton MC (eds). Parthenon Publishing Group Limited: Carnforth, 1992; 183189.
  • 39
    Tulppala M, Marttunen M, Soderstrom-Anttila V, Foudila T, Ailus K, Palosuo T, Ylikorkala O. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod 1997; 12: 15671572.
  • 40
    Vainio M, Kujansuu E, Iso-Mustajarvi M, Maenpaa J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002; 109: 161167.
  • 41
    Villa PM, Kajantie E, Raikkonen K, Pesonen AK, Hamalainen E, Vainio M, Taipale P, Laivuori H. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 2013; 120: 6474.
  • 42
    Byaruhanga RN, Chipato T, Rusakaniko S. A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia. Int J Gynaecol Obstet 1998; 60: 129135.
  • 43
    Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 338: 701705.
  • 44
    CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994; 343: 619629.
  • 45
    Davies N, Gazvani M, Farquharson R, Walkinshaw S. Low-dose aspirin in the prevention of hypertensive disorders of pregnancy in relatively low-risk nulliparous women. Hypertens Pregnancy 1995; 14: 4955.
  • 46
    ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group. Br J Obstet Gynaecol 1996; 103: 3947.
  • 47
    Ferrier C, North R, Kincaid-Smith P. Low dose aspirin delays the onset of pre-eclampsia in pregnancies with abnormal uteroplacental circulation. Proceedings of the 10th World Congress of the International Society for the Study of Hypertension in Pregnancy, August 4–8, 1996, Seattle, WA, USA, p. 151.
  • 48
    Gallery E, Ross M, Hawkins M, Leslie G, Gyory A. Low-dose aspirin in high-risk pregnancy. Hypertens Pregnancy 1997; 16: 229238.
  • 49
    Grab D, Paulus WE, Erdmann M, Terinde R, Oberhoffer R, Lang D, Muche R, Kreienberg R. Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol 2000; 15: 1927.
  • 50
    Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. Br J Obstet Gynaecol 1998; 105: 293299.
  • 51
    Hauth JC, Goldenberg RL, Parker CR Jr, Philips JB 3rd, Copper RL, DuBard MB, Cutter GR. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 1993; 168: 10831091.
  • 52
    Kim HS, Kim KS, Kim TY, Cho JS, Park YW, Song CH. Clinical efficacy of doppler ultrasound for low dose aspirin therapy in high risk pregnancy. Korean J Obstet Gynecol 1997; 40: 7177.
  • 53
    McCowan LM, Harding J, Roberts A, Barker S, Ford C, Stewart A. Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial. Br J Obstet Gynaecol 1999; 106: 647651.
  • 54
    McParland P, Pearce JM, Chamberlain GV. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990; 335: 15521555.
  • 55
    Morris JM, Fay RA, Ellwood DA, Cook CM, Devonald KJ. A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. Obstet Gynecol 1996; 87: 7478.
  • 56
    Newnham J, Godfrey M, Walters B, Philips J, Evans S. Low dose aspirin for the treatment of fetal growth restriction: a randomised controlled trial. Aust N Z J Obstet Gynaecol 1995; 35: 370374.
  • 57
    Omrani GR, Karimi MM, Zareh F. Prevention of pregnancy-induced hypertension by low dose aspirin. Iran J Med Sci 1992; 17: 131136.
  • 58
    Rogers MS, Fung HY, Hung CY. Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension. Hypertens Pregnancy 1999; 18: 165172.
  • 59
    Rotchell YE, Cruickshank JK, Gay MP, Griffiths J, Stewart A, Farrell B, Ayers S, Hennis A, Grant A, Duley L, Collins R. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol 1998; 105: 286292.
  • 60
    Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Yahal I, Blankstein J, Goldman B, Mashiach S. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989; 321: 351356.
  • 61
    Schrocksnadel H, Sitte B, Alge A, Stechel-Berger G, Schwegel P, Pastner E, Daxenbichler G, Hansen H, Dapunt O. Low-dose aspirin in primigravidae with positive rollover test. Gynecol Obstet Invest 1992; 34: 146150.
  • 62
    Trudinger B, Cook CM, Thompson R, Giles W, Connelly A. Low-dose aspirin improves fetal weight in umbilical placental insufficiency. Lancet 1988; 2: 214215.
  • 63
    Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986; 1: 13.
  • 64
    Wallenburg HC, Dekker GA, Makovitz JW, Rotmans N. Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women. Am J Obstet Gynecol 1991; 164: 11691173.
  • 65
    Wang Z, Li W. A prospective randomized placebo-controlled trial of low-dose aspirin for prevention of intra-uterine growth retardation. Chin Med J (Engl) 1996; 109: 238242.
  • 66
    Wu J, Yang W, Shen W, He Y. Small dosage aspirin in the prevention of hypertension of pregnancy. Acta Academiae Medicinae Suzhou 1996; 16: 551553.
  • 67
    Yu CK, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KH. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol 2003; 22: 233239.
  • 68
    Zimmermann P, Eirio V, Koskinen J, Niemi K, Nyman R, Kujansuu E, Ranta T. Effect of low-dose aspirin treatment on vascular resistance in the uterine, uteroplacental, renal and umbilical arteries – A prospective longitudinal study on a high risk population with persistent notch in the uterine arteries. Eur J Ultrasound 1997; 5: 1730.
  • 69
    Sterne JA, Egger M, Smith GD. Systematic 7 in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 101105.
  • 70
    Lyall F, Bulmer JN, Duffie E, Cousins F, Theriault A, Robson SC. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol 2001; 158: 17131721.
  • 71
    Robson S, Ball E, Lyall F, Simpson H, Ayis H, Bulmer J. Endovascular trophoblast invasion and spiral artery transformation: the “two wave” theory revisited. Placenta 2001; 22: A25.
  • 72
    Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4: 397413.
  • 73
    Robertson WB, Khong TY, Brosens I, De Wolf F, Sheppard BL, Bonnar J. The placental bed biopsy: review from three European centers. Am J Obstet Gynecol 1986; 155: 401412.
  • 74
    Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, Thaler HT, Romero R. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187: 11371142.
  • 75
    Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011; 39: 641652.
  • 76
    Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006; 86: 362366.
  • 77
    Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, Thaler HT, Rotmensch S, Romero R. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003; 189: 10631069.
  • 78
    Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007; 30: 742749.
  • 79
    Baschat AA, Poon LY, Blitzer M, Nicolaides KH, Harman C. Impact of 1st trimester aspirin on population prevalence of preeclampsia. Ultrasound Obstet Gynecol 2009; 34: 14.
  • 80
    Crandon AJ, Isherwood DM. Effect of aspirin on incidence of pre-eclampsia. Lancet 1979; 1 (8130): 1356.
  • 81
    Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG. Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet 1979; 2 (8154): 12131217.
  • 82
    Ministry of Health Report. 1929 Memorandum on Antenatal Clinics: Their Conduct and Scope. His Majesty's Stationery Office: London, 1930.
  • 83
    Nicolaides KH. Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183196.
  • 84
    Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 2011; 31: 6674.
  • 85
    Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound Obstet Gynecol 2010; 35: 662670.
  • 86
    Poon LC, Volpe N, Muto B, Yu CK, Syngelaki A, Nicolaides KH. Second-trimester uterine artery doppler in the prediction of stillbirths. Fetal Diagn Ther 2013; 33: 2835.